Log in

Start Your Membership Now

November 19, 2009 The U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application for Abilify (aripiprazole) to treat irritability associated with autism in children aged six to 17. The approval was based on the results of two eight-week, randomized, double-blind placebo-controlled studies which compared the effectiveness of Abilify in reducing irritability and aggression to a placebo. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resource | November 19, 2009

FDA Approval Letter to Bristol-Myers Squibb for the Pediatric Use of Abilify to Treat Irritability Associated With Autism

November 19, 2009 The U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application for Abilify (aripiprazole) to treat irritability associated with autism in children aged six to 17. The approval was based on the results of two eight-week, randomized, double-blind placebo-controlled studies which compared the effectiveness of Abilify in reducing irritability and aggression to a placebo. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.